Omalizumab Increases the Reaction Threshold for Peanut and Other Common Food Allergies
Study highlights a valuable option for safe and effective food allergy treatment. WASHINGTON, Feb. 25, 2024 /PRNewswire-PRWeb/ -- Sixteen weeks of omalizumab results in a higher tolerated threshold for multiple food allergies according to new research presented today at the 2024 American...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI SVY Source Type: news
More News: Allergy | Allergy & Immunology | Food Allergy | Peanuts | Pharmaceuticals | Study | Xolair